MoneyWorks4Me

Oxygenta Pharmaceutical informs about disclosure

03 Oct 2024 Evaluate
Oxygenta Pharmaceutical has informed that it enclosed disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for M V S Prasad Reddy & PACs.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..